Skip to main content
. 2021 Apr-Jun;25(2):e2021.00027. doi: 10.4293/JSLS.2021.00027

Table 2.

Systematic Review of the Literature

Author Patients Incidence of Shoulder Pain (%)
n 1 h 2 h 3 h 4 h 6 h 8 h 12 h 24 h 48 h Overall
LTV group 28 21.4 39.3 46.4a 32.1 57.1
Liu2 Total 60 11.7 30 35 36.6a 20
Group 1 30 86
Group 2 30 67
Kerimoglu3 Total 93
Drain group 44 63.6a 43.6
No-drain group 49 67.8a 48.2
Abbott4 Total 161
Placebo group 79 24 34a 20
Drain group 82 12 23a 8
Bogani5 Total 42
LPP group 20 5 10 5
SPP group 22 36 41a 5
Sharami6 Total 131 54.2 58a 48.9 58
Control group 64
Intervention group 67
Shen7 Total 164
Drains group 80 11 23a 9
No-drains group 84 20 40a 21
Zhang8 Total 123 Rest/motion 54
Group C 42 12.3/28.6 40.5/57.1a 12.3/38.1 61.9
Group M 40 7.5/22.5 17.5/37.5a 10/17.5 37.5
Group S 41 12.2/19.5 22/58.5a 12.2/37.1 61

Values are meant as median (SD) unless indicated otherwise.

Overall: the total incidence of PLSP during postoperative observation (in each group, the number of patients with VAS = 0 at each time point was recorded to evaluate the overall incidence of PLSP); LPP group: low pneumoperitoneum pressure group; SPP group: standard pneumoperitoneum pressure group.

aThe patient's shoulder pain reached its peak.